Treatment response to sunitinib in imatinib-resistant recurrence of dermatofibrosarcoma protuberans on the capillitium

被引：0
|
作者：
Mueller, C. [1 ]
Scheib, C. [1 ]
Peller, V. [1 ]
Zillikens, H. [1 ]
Rudolph, V. [1 ]
Leven, A. S. [1 ]
Bauer, S. [2 ]
Pretzell, I. [3 ]
Griewank, K. [1 ]
Sucker, A. [1 ]
Hadaschik, E. [1 ]
Roesch, A. [1 ,2 ]
Ugurel, S. [1 ]
Schadendorf, D. [1 ,2 ]
Zimmer, L. [1 ]
Livingstone, E. [1 ]
机构：
[1] Univ Klinikum Essen, Dermatol, Essen, Germany
[2] Deutsches Konsortium Translat Krebsforsch DKTK, Essen, Germany
[3] Univ Klinikum Essen, Westdeutsches Tumorzentrum, Essen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP119
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [31] Response to imatinib mesylate (IM) in fibrosarcoma (FS) arising in dermatofibrosarcoma protuberans (DFSP)
    Gronchi, A.
    Stacchiotti, S.
    Pedeutour, F.
    Collini, P.
    Tamborini, E.
    Morosi, C.
    Crippa, F.
    Pastorino, U.
    Pilotti, S.
    Casali, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Effect of sunitinib in a patient with primary imatinib-resistant gastrointestinal stromal tumor.
    Xue, Zhigang
    Ma, Zhiqiang
    Kang, Weiming
    Yu, Jianchun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Treatment of Advanced Dermatofibrosarcoma Protuberans (DFSP) with Imatinib Mesylate and with or without Surgical Resection
    Rutkowski, P.
    Debiec-Rychter, M.
    Nowecki, Z. I.
    Zdzienicki, M.
    Ruka, W.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S31 - S31
  • [34] Effectiveness of Imatinib Mesylate Treatment in a Patient with Dermatofibrosarcoma Protuberans with Pulmonary and Pancreatic Metastases
    Tatai, Toshiharu
    Gomi, Daisuke
    Fukushima, Toshirou
    Kobayashi, Takashi
    Sekiguchi, Nodoka
    Sakamoto, Akiyuki
    Sasaki, Shigeru
    Koizumi, Tomonobu
    Sano, Kenji
    INTERNAL MEDICINE, 2016, 55 (17) : 2507 - 2511
  • [35] Successful treatment of unresectable dermatofibrosarcoma protuberans on finger with imatinib mesylate and Mohs microsurgery
    Jeon, In Kyung
    Kim, Jong Hoon
    Kim, Song-ee
    Kim, Soo-Chan
    Roh, Mi Ryung
    JOURNAL OF DERMATOLOGY, 2013, 40 (04): : 288 - 289
  • [36] Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery
    Wright, Tina I.
    Petersen, Jeffrey E.
    DERMATOLOGIC SURGERY, 2007, 33 (06) : 741 - 744
  • [37] Sunitinib activity in imatinib-resistant GITS patients: Correlation with KIT and PDGFRA mutation status
    Corless, C.
    Demetri, G.
    Maki, R.
    Antonescu, C.
    Fletcher, J.
    Fletcher, C.
    Huang, X.
    Baum, C.
    Heinrich, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 22 - 22
  • [38] Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
    Lin Shen
    Yan Sun
    Jian-Ming Xu
    Carlos Linn
    Qiao Wang
    Li-Qiang Yang
    Shu-Kui Qin
    Oncology and Therapy, 2017, 5 (2) : 171 - 180
  • [39] Treatment options in imatinib-resistant chronic myelogenous leukemia
    Marshall, Helen M.
    Hammond, Julia M.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (02) : 259 - 264
  • [40] Efficacy and safety of sunitinib in Chinese patients with imatinib-resistant or -intolerant gastrointestinal stromal tumors
    Li, Jian
    Gao, Jing
    Hong, Jinlin
    Shen, Lin
    FUTURE ONCOLOGY, 2012, 8 (05) : 617 - 624
12345